Obermatt
See Similar Stocks →

Bayer CropScience

NSI:BAYERCROP · INE462A01022
ChemicalsMedium

360

60
Medium confidence — indicative
Profit price21
Owner Earnings Yield70
Dividend Yield1
Price/Sales48
EV / Gross Profit27
Price/Book25
Return on Capital92
Cash Return on Capital100
Return on Equity92
EBIT Margin68
Gross Profitability94
Cash Conversion48
Owner Earnings Margin84
Sales growth18
Profit Growth50
Long-Term EPS Growth22
Reinvestment20
Price momentum32
Debt load80
Refinancing60
Debt Payback100
Liquidity87
Analyst ratings33
Opinion Changes50
Price Target Upside79
Market mood33
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Bayer CropScience clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Based on 3/5 components.

Profile

CountryGermany
IndustryChemicals
SizeMedium
TypePublic Company
ExchangeBSE
Founded1958
Employees4
Websitebayer.in
ISININE462A01022
Last UpdateApr 2, 2026
Index & Theme
Industrial AutomationAgriTechPredictive AnalyticsGeneticsFarming

Description

Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and corn seeds. Business Segments The company operates through distinct yet interconnected…

Analysis

Quality compounder

Bayer CropScience Limited is a quality compounder: a well-run business trading at a price that reflects what it is worth. One caution: reported profits have recently run ahead of actual cash, which we track closely.

The price is fair. You pay 23.4× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone. At today's price, the market is assuming roughly 8% yearly growth; analysts expect -20%. The market is pricing in far more than analysts expect: heroic expectations.

The trajectory is tepid and the balance sheet is sturdy. The company scores 10/20 on our value-creation score: creating some value. Analyst sentiment is cautious.

What to watch: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
32
2023202420252026

All-time high

92

Mar 2026

All-time low

32

Jun 2026

Average rank

63

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
48
57
54
54
Price/Earnings
19
46
46
44
Price/Book
25
34
23
39
Dividend Yield
1
77
57
30
Value (overall)
5
63
53
49

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Bayer CropScience with its peers
Bioceres Crop
NSQ:BIOX
15
CountryUK
IndustryChemicals
SizeSmall
Full Stock Analysis →
Virbac
PAR:VIRP
58
CountryFrance
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Genfit
PAR:GNFT
32
CountryFrance
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Sandoz
SWX:SDZ
18
CountrySwitzerland
IndustryPharmaceuticals
SizeX-Large
Full Stock Analysis →
K&S
GER:SDF
26
CountryGermany
IndustryChemicals
SizeLarge
Full Stock Analysis →
Fermentalg
PAR:ALGAE
39
CountryFrance
IndustryChemicals
SizeX-Small
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →